Amgen Building 31

Amgen is a leading human therapeutics company in the biotechnology industry. Since 1980, the company has tapped the power of scientific discovery and innovation to improve people s lives. Products include Aranesp, Enbrel, EPOGEN, Kepivance, Kineret, Neulasta, NEUPOGEN and Sensipar. Amgen pioneered the development of novel products based on advances in recombinant DNA and molecular biology and launched the biotechnology industry s first blockbuster medicines. As a Fortune 500 company serving millions of patients, Amgen continues to be an entrepreneurial, science-driven enterprise dedicated to helping people fight serious illness. The company, which trades on NASDAQ under the ticker symbol AMGN, has a location in Thousand Oaks, Calif.

Amgen USA Inc, located in Newbury Park, CA, is a global leader in biotechnology, dedicated to advancing innovative therapies across various therapeutic areas including oncology, cardiovascular health, and rare diseases. The company emphasizes a commitment to research and development, utilizing cutting-edge technologies such as AI and DNA-encoded libraries to enhance drug design and optimize clinical trials. With a strong focus on corporate responsibility, Amgen prioritizes health equity, environmental sustainability, and community investment through initiatives like the Amgen Foundation. The company is also recognized for its commitment to diversity, inclusion, and ethical practices in research and development, ensuring patient safety and product quality at every stage of its operations. Generated from the website